Follow
There is not yet a treatment of multiple sclerosis. Innovative medicines can make a major difference to patients’ life. Protection of IP is key to scientific progress. Our concern is that @tevapharm may have misused the patent system to shield itself from competition. See more ⬇️
RT @EU_Competition: Commission 🇪🇺 sends Statement of Objections to Teva over misuse of the patent system and disparagement of rival multiple sclerosis #medic…
